Personalized management of prostate cancer: from molecular and imaging markers to radiogenomics

PURPOSE: Prostate cancer (PCa) is the second most common cancer in men. The urge to guide treatment tactics based on personal clinical risk factors has evolved in the era of human genome sequencing. To date, personalized approaches to managing PCa patients have not yet been developed. Radiogenomics...

Descripción completa

Detalles Bibliográficos
Autores principales: Mytsyk, Yulian, Borzhiyevs’kyy, Andriy, Kobilnyk, Yuriy, Shulyak, A.V., Dutka, Ihor, Borzhiyevs’kyy, Oleksandr, Górecki, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814894/
https://www.ncbi.nlm.nih.gov/pubmed/35140829
http://dx.doi.org/10.5114/pjr.2022.113204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814894/
https://www.ncbi.nlm.nih.gov/pubmed/35140829
http://dx.doi.org/10.5114/pjr.2022.113204

Ejemplares similares